• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Therapeutic efficacy and mechanism of heat-sensitive moxibustion for adjuvant treatment of depression in Parkinson disease

    2020-02-28 08:46:08WangXiaomei王笑媚RongChunjiao榮春嬌

    Wang Xiao-mei (王笑媚), Rong Chun-jiao (榮春嬌)

    Lishui Second People’s Hospital, Zhejiang 323000, China

    Abstract

    Keywords: Moxibustion Therapy; Moxa Stick Moxibustion; Heat-sensitive Moxibustion; Quality of Life; Mental Status and Dementia Tests; Parkinson Disease; Depression

    Parkinson disease (PD) is a chronic and progressive neurodegenerative disease pathologically characterized by the loss of dopaminergic neurons in the substantia nigra and the dysfunction of dopamine (DA) pathway in the striatum, and clinically characterized by bradykinesia, myotonia, tremor, abnormal posture and gait[1].As the disease progresses, non-motor symptoms of PD also gradually occur, among which, depression is more common, with the incidence rate as high as 35%-50%[2].Parkinson disease with depression (PDD)can lead to the decrease of cognitive ability, the decrease of daily quality of life and the increase of suicide rate, which has a very negative impact on families and society[3].For PDD, DA receptor agonists,tricyclic antidepressants, and 5-hydroxytryptamine(5-HT) reuptake inhibitors are mainly used in clinic, and appropriately combined with cognitive behavioral therapy, electric shock therapy, psychotherapy and other auxiliary therapies[4].However, the efficacy of drug is limited, the action is slow, the treatment course is long, the cost is high, and the adverse reactions are obvious, while the curative effect is not stable.The auxiliary therapies lack of professionals, and its clinical popularization rate needs to be improved[5].

    PDD belongs to tremor syndrome and depression syndrome in traditional Chinese medicine (TCM).TCM has a certain effect in treating PDD[6-7], and patients have better compliance.As one kind of the TCM therapies, moxibustion has been reported in many clinical studies in the treatment of PD and depression[8-9], and its safety has been widely recognized.However, there are few reports on the clinical efficacy and mechanism of moxibustion for PDD.

    In this study, we observed the clinical efficacy of heat-sensitive moxibustion for the treatment of PDD,and its effects on the levels of neurotransmitters and inflammatory factors.

    1 Clinical Materials

    1.1 Case selection

    1.1.1 Diagnostic criteria in Western medicine

    Met the diagnostic criteria of PD in theChinese Guideline for Treatment of Parkinson Disease(3rd edition)[10].Met the diagnostic criteria of depression in the 3rd edition ofChinese Classification and Diagnosis of Mental Diseases(Classification of Mental Disorders)[11].

    1.1.2 Criteria for syndrome differentiation of traditional Chinese medicine (TCM)

    Syndrome differentiation classification referred to the criteria of syndrome of qi and blood depletion in theGuiding Principles for Clinical Study of New Chinese Medicines[12].Primary manifestations: tremor of head or limbs, less movement, over-thinking and being anxious, palpitations and timidity.Secondary manifestations: hypomimia, dim complexion, dizziness and spiritlessness, anorexia, a pale teeth-printed tongue with white coating, deep pulse or weak pulse.

    1.2 Inclusion criteria

    Those who met the above diagnostic criteria of PD in Western medicine and syndrome of qi and blood depletion for syndrome differentiation of TCM; aged 40-80 years; Hamilton depression scale-17(HAMD-17) >13 points[13]; agreed to participate in this trial and signed informed consent.

    1.3 Exclusion criteria

    Patients with non-PD diseases such as hepatolenticular degeneration, hepatic encephalopathy,essential tremor; those with severe diseases of heart,brain, liver or kidney; women during pregnancy or lactation; those were unconscious or unable to cooperate with the trial; those who were allergic to the medication.

    1.4 Statistical methods

    All data were statistically analyzed by the SPSS version 20.0 statistical software.Chi-square test was applied to the comparison of counting data.Measurement data were first tested for normality and homogeneity of variance.Those in normal distribution and had homogeneous variance were expressed as mean ± standard deviation (±s), andt-test was applied.T’-test was applied for data with uneven variance.If data did not meet the normal distribution,non-parametric test was applied.P<0.05 was considered to indicate a statistically significant difference.

    1.5 General data

    A total of 80 patients who met the inclusion criteria of PDD were enrolled from our hospital between September 2016 and January 2019.All patients were randomly divided into an observation group and a control group by the random number table, with 40 cases in each group.There was no dropout case during the study.The patients in the observation group were aged between 48 and 80 years, with the shortest duration of 9 months and the longest of 93 months.The patients in the control group were aged between 51 and 80 years, with the shortest duration of 6 months and the longest of 92 months.There were no significant differences in the data of gender, age and duration of disease between the two groups (allP>0.05), indicating that the two groups were comparable (Table 1).

    Table 1.Comparison of general data between the two groups

    2 Treatment Methods

    2.1 Control group

    Patients in the control group received conventional symptomatic treatment of Western medicine, and the efficacy was observed after continuous 2-month treatment.

    Anti-PD treatment: Oral levodopa and benserazide hydrochloride tablets (national drug registration number: H10930198, Shanghai Roche Pharmaceutical Co., Ltd., China), starting at 0.125 g per time, three times a day.Added 0.125 g per week after starting the medicine, and maintained the dosage after the symptoms improved.

    Antidepressant treatment: Oral paroxetine tablets(national drug registration number: H10950043,Sino-American Tianjin Shike Pharmaceutical Co., Ltd.,China), 20 mg, once a day.

    2.2 Observation group

    2.2.1 Medications

    The observation group received the same medications as the control group.

    2.2.2 Heat-sensitive moxibustion

    Acupoints: Qihai (CV 6) and bilateral Xuehai (SP 10),Zusanli (ST 36), Xinshu (BL 15) and Pishu (BL 20).

    Moxa stick specifications: Hwato Brand pure moxa sticks of 1.8 cm in diameter and 20 cm in length were used for moxibustion (Nanyang Wolong Chinese Medicine Moxa Factory, China).

    Methods: Acupoint locations referred to theScience of Meridians and Acupoints[14].The heat-sensitive moxibustion operation referred to theAcupoint Heatsensitization Moxibustion:A New Moxibustion Therapy[15].The patient took a supine position, exposing the acupoints.After receiving moxibustion at frontal points, the patient changed to the prone position.The physician sought heat-sensitized points first, which was to apply circling moxibustion and mild moxibustion to the acupoints with an ignited moxa stick 3-5 cm away from skin.When patient felt heat penetration, heat expansion, heat transmission or heat in distant area but not in local area, that would be the heat-sensitized point.Then the physician continued to perform mild moxibustion at this heat-sensitized point till the disappearance of the heat sensitization.The physician repeated the above steps until the selected acupuncture points were completed for moxibustion in turn.The heat-sensitive moxibustion was performed once a day for 2 months.

    3 Observation of Curative Efficacy

    3.1 Observation items

    3.1.1 HAMD-17 score

    HAMD-17 was scored before and after treatment for the two groups by the same neurologist not knowing about grouping.The HAMD-17 score ranges from 0 to 53 points, and higher scores indicate more severe depressive symptoms.PD patients with a HAMD-17 score >13 points were considered to be depressed.HAMD-17 has high sensitivity and specificity that can be used for screening and severity assessment of PDD[13].

    3.1.2 Unified Parkinson's disease rating scale (UPDRS)

    UPDRS was scored before and after treatment for the two groups by the same neurologist not knowing about grouping.UPDRS consists of Ⅰ (mind, behavior and emotion), Ⅱ (activities of daily living), Ⅲ (motor examination) and Ⅳ (complications).The total score is 199 points, and the higher the score, the more severe the condition of PD patients[16].

    3.1.3 Parkinson's disease quality of life questionnaire-39 (PDQ-39)

    Before and after treatment, patients in both groups filled the PDQ-39 according to their actual situation in the last month.PDQ-39 consists of 8 dimensions,including physical activity, daily behavioral activities,mental health, humiliation, social support, cognition,communication and physical discomfort, with a total of 39 subjects and a score ranging from 0 to 156 points.The higher the score, the worse the quality of life[17].

    3.1.4 Neurotransmitter and inflammatory factors detection

    The fasting venous blood in the morning was collected before and after treatment.The serum DA,5-HT, tumor necrosis factor-α (TNF-α) and interleukin-6(IL-6) levels of the two groups were measured before and after treatment by enzyme-linked immunosorbent assay (ELISA).

    3.2 Criteria of curative efficacy

    The reduction rate of HAMD-17 score was used as the criteria of efficacy evaluation[18].

    HAMD-17 reduction rate = (Score before treatment -Score after treatment) ÷ Score before treatment ×100%.

    Cured: The main symptoms basically disappeared.HAMD-17 reduction rate ≥90%.

    Marked effect: The main symptoms were significantly improved.HAMD-17 reduction rate ≥60%, but <90%.

    Effective: The main symptoms were improved.HAMD-17 reduction rate ≥30%, but <60%.

    Invalid: The main symptoms were not obviously improved or even worse.HAMD-17 reduction rate<30%.

    3.3 Results

    3.3.1 Clinical efficacy

    The total effective rate was 95.0% in the observation group and 72.5% in the control group.The total effective rate of the observation group was higher than that of the control group (χ2=7.44,P=0.006), (Table 2).

    Table 2.Comparison of clinical efficacy between the two groups (case)

    3.3.2 HAMD-17 score

    There was no significant difference in the HAMD-17 score between the two groups before treatment(P>0.05).After treatment, the HAMD-17 scores in both groups decreased obviously (bothP<0.05), and the HAMD-17 score in the observation group was significantly lower than that in the control group(P<0.05), (Table 3).

    3.3.3 UPDRS score

    There were no significant differences in the UPDRS component and total scores between the two groups before treatment (allP>0.05).After treatment, the UPDRS component and total scores in both groups decreased significantly (allP<0.05), and all the scores in the observation group were lower than those in the control group (allP<0.05), (Table 4).

    Table 3.Comparison of the HAMD-17 score between the two groups (±s, point)

    Table 3.Comparison of the HAMD-17 score between the two groups (±s, point)

    Note: Compared with the same group before treatment, 1)P<0.05; compared with the control group after treatment, 2)P<0.05

    Group n Before treatment After treatment Observation 40 21.75±5.55 14.43±4.961)2)Control 40 21.55±5.61 17.78±4.421)

    Table 4.Comparison of UPDRS scores between the two groups (±s, point)

    Table 4.Comparison of UPDRS scores between the two groups (±s, point)

    Note: BT=Before treatment; AT=After treatment; compared with the same group before treatment, 1) P<0.05; compared with the control group after treatment, 2) P<0.05

    Motor examination Complications Total 23.80±2.68 6.53±1.11 52.28±3.52 19.50±2.001)2) 3.83±0.781)2) 37.53±2.861)2)24.60±2.22 6.43±1.17 52.88±3.47 21.38±2.021) 4.88±0.791) 45.65±2.951)

    3.3.4 PDQ-39 score

    There was no significant difference in the PDQ-39 score between the two groups before treatment(P>0.05).After treatment, the PDQ-39 scores in both groups decreased significantly (bothP<0.05), and the PDQ-39 score in the observation group was significantly lower than that in the control group (P<0.05), (Table 5).

    3.3.5 Serum DA and 5-HT levels

    There were no significant differences in the serum DA and 5-HT levels between the two groups before treatment (bothP>0.05).After treatment, the DA and 5-HT levels in the observation group increased significantly (bothP<0.05), and were higher than those in the control group (bothP<0.05), (Table 6).

    Table 5.Comparison of the PDQ-39 score between the two groups (±s, point)

    Table 5.Comparison of the PDQ-39 score between the two groups (±s, point)

    Note: Compared with the same group before treatment, 1)P<0.05; compared with the control group after treatment, 2)P<0.05

    Observation 40 65.98±8.69 48.35±8.401)2)Control 40 64.10±7.96 56.20±7.591)

    Table 6.Comparison of the serum DA and 5-HT levels between the two groups (±s)

    Table 6.Comparison of the serum DA and 5-HT levels between the two groups (±s)

    Note: Compared with the same group before treatment, 1) P<0.05; compared with the control group after treatment, 2) P<0.05

    Group n DA (pg/mL) 5-HT (ng/mL)Before treatment After treatment Before treatment After treatment Observation 40 42.73±3.51 64.75±4.071)2) 158.21±21.89 256.95±26.541)2)Control 40 42.12±3.21 42.53±3.94 161.26±22.74 165.27±23.76

    3.3.6 Serum TNF-α and IL-6 levels

    There were no significant differences in the serum TNF-α and IL-6 levels between the two groups before treatment (bothP>0.05).After treatment, the TNF-α and IL-6 levels in the observation group decreased significantly (bothP<0.05), and were lower than those in the control group (bothP<0.05), (Table 7).

    3.3.7 Adverse reactions

    During the treatment, there were 2 cases of mild diarrhea, 2 cases of nausea and vomiting and 3 cases of dizziness in the control group.There was 1 case of vomiting occurred in the observation group.The incidence of adverse reactions in the control group was 17.5%, which was significantly higher than that in the observation group (2.5%,χ2=5.00,P=0.025).The adverse reactions in the two groups were minor and all self-relieved within a short time.After treatment, there were no obvious abnormal changes in blood, urine,stool, liver and kidney function in all participants.

    Table 7.Comparison of the TNF-α and IL-6 levels between the two groups (±s, pg/mL)

    Table 7.Comparison of the TNF-α and IL-6 levels between the two groups (±s, pg/mL)

    Note: Compared with the same group before treatment, 1) P<0.05; compared with the control group after treatment, 2) P<0.05

    Group n TNF-α IL-6 Before treatment After treatment Before treatment After treatment Observation 40 432.93±59.48 333.87±45.241)2) 26.96±3.08 18.90±3.351)2)Control 40 445.98±53.86 430.06±49.03 26.28±2.86 25.74±3.08

    4 Discussion

    The pathogenesis of PDD is not clear.At present, it is believed that it is mainly caused by endogenous biological factors and exogenous psychological factors.Study showed that there was no significant correlation between the severity of depression and the progress of PD, and some of the depression symptoms appeared before motor symptoms, some occurred at the same time, and some after medications[19].It was clear that although bad mind and emotions such as delusion,despair and inferiority caused by the aggravation of motor dysfunction and the decline of social function and adaptability could indeed lead to the occurrence of depressive symptoms, the endogenous biological factors were the most primary cause of PDD.

    Abnormalities in neurotransmitters such as DA and 5-HT play an important role in the occurrence and progress of PDD.DA is a neurotransmitter involved in the regulation of both motor function and emotional activity.The main biochemical change of PD is the significant decrease of DA content in the brain.The typical motor symptoms of PD only occur when the dopaminergic neurons in the substantia nigra is reduced by more than 50% and DA content in the basal ganglia is reduced by more than 80%.Decreased DA neurons in the central system can also lead to reduced or lost happiness, apathy and the decrease of consciousness activities.Both PD patients and patients with depression have corpus striatum DA system dysfunction.Depression symptoms are one of the basic manifestations of PD patients with impaired dopaminergic pathways in the central frontal cortex[20].In addition to dopaminergic system, PD with depression is also related to abnormal 5-HT system.Clinical study showed that the serum 5-HT level was significantly reduced in patients with PD and depression, and 5-HT receptor antagonists could improve depressive symptoms in PD patients[19].5-HT transporters are also related to PDD, and can reflect the functional status of 5-HT neurons.It was found that the marker signal of 5-HT transporter in the nucleus raphes dorsalis was significantly reduced in the brain specimens of PD patients, indicating that there was 5-HT neuron dysfunction in PD patients[21].In addition, the feedback mechanism of 5-HT on DA is also involved in pathogenic process of PDD.Under physiological conditions, 5-HT inhibits the release of DA, while with the decrease of the DA level, the 5-HT level decreases, leading to the onset of PDD.

    Recent studies suggested that inflammatory factors such as TNF-α and IL-6 might also cause depression in PD patients.It was found that the serum TNF-α and IL-6 levels in PDD patients were significantly lower than those in healthy participants.After treatment, the levels of inflammatory factors were corrected to some extent[22], which suggested that the levels of inflammatory factors might be related to cognitive dysfunction in patients with PDD and might reflect the severity of cognitive impairment.Inflammatory cytokines may induce dopaminergic neuron cell damage by stimulating microglia, and also lead to apoptosis by combining with dopaminergic neuron cells and participate in the pathogenesis of PD[23].At the same time, over-expressed inflammatory cytokines aggravate immune damage, affect the expressions of hypothalamic-pituitary-adrenal cortex axis hormones and neurotransmitters such as DA and 5-HT, and induce emotional disorders such as depression[24].

    According to the clinical manifestation of PDD, it falls under the category of tremor syndrome and depression syndrome in TCM.There is no consensus on pathogenesis and TCM pattern.For example, Song QY[25]advocated that it should be divided into three patterns:yin deficiency of liver and kidney, internal stirring of deficient wind; yang deficiency of spleen and kidney,internal blockade of phlegm stagnation; deficiency of both qi and blood, static blood blocking collaterals.However, study on TCM pattern showed that syndrome of qi and blood depletion was one of the most common syndromes in PD patients[26], and syndrome of qi and blood depletion of heart and spleen was a common pattern in patients with depression[27].PD patients with emotional disorders were more likely to have qi deficiency[28].It is clear that deficiency of both qi and blood syndrome is one of common syndromes in clinic.Therefore, the treatment principles should be benefiting qi for promoting production of blood and invigorating heart and spleen.

    The heat-sensitive moxibustion is a new therapy characterized by applying suspended moxibustion to heat-sensitized acupoints.It has effects of traditional moxibustion such as warming for unblocking, warming for invigoration and mutual application of unblockinginvigorating.It is also suitable for deficiency syndrome,cold syndrome and meridian qi and blood blockage syndrome.In addition, the heat-sensitive moxibustion pays more attention to the transmission of meridian provoked by moxibustion, so that qi can reach the disease location, thus producing a more significant therapeutic effect compared with the traditional moxibustion.

    In this study, Qihai (CV 6), Xuehai (SP 10), Zusanli(ST 36), Xinshu (BL 15) and Pishu (BL 20) were selected for moxibustion.Qihai (CV 6) is the Yuan-Primary point of Huang (the region around the navel), the sea of qi generation and the gathering place of primordial qi.Moxibustion at Qihai (CV 6) has the effect of benefiting qi and regulating qi flow.Xuehai (SP 10) can activate blood and resolve stasis, replenish and nourish blood,and lead blood back to the channel.For treating blood-related diseases, combination of Xuehai (SP 10)and Qihai (CV 6) has the effects of replenishing and nourishing blood, moving qi and activating blood, and promoting meridians and dissipating stasis.Zusanli(ST 36) is the He-Sea point of the Stomach Meridian and the Lower He-Sea point of stomach, with the effect of invigorating spleen and stomach, harmonizing qi and blood, strengthening vital qi and primordial energy.Xinshu (BL 15) and Pishu (BL 20) are the Back-Shu points of heart and spleen, respectively.They can invigorate heart and spleen and promote the derivation of qi and blood.They are the key points to treat diseases of heart and spleen.The combination of the above five acupoints can produce the effect of benefiting qi and activating qi flow, nourishing blood and promoting blood circulation, and invigorating spleen for benefiting heart.

    Results of this study showed that the clinical effective rate of the observation group was significantly higher than that of the control group.After treatment, the HAMD-17 score, the UPDRS component and total scores in the observation group were improved obviously, and superior to those in the control group.The PDQ-39 score in the observation group decreased obviously after treatment, and was lower than that in the control group.The serum DA and 5-HT levels in the observation group increased significantly after treatment, and the TNF-α and IL-6 levels decreased significantly, which were all significantly different from those in the control group.The above results indicated that heat-sensitive moxibustion had certain assistant effect in treating PDD that could significantly improve clinical symptoms.It had obvious antidepressant effect,and could improve quality of life of patient, which may be related to the up-regulation of DA and 5-HT levels and the down-regulation of TNF-α and IL-6 levels.

    老司机福利观看| 叶爱在线成人免费视频播放| 国产精品久久电影中文字幕 | 如日韩欧美国产精品一区二区三区| 国产精品免费一区二区三区在线 | xxxhd国产人妻xxx| 天天躁日日躁夜夜躁夜夜| 亚洲 欧美一区二区三区| 国内毛片毛片毛片毛片毛片| 高清视频免费观看一区二区| 亚洲av成人av| 成人免费观看视频高清| 黄色视频,在线免费观看| 91av网站免费观看| 啪啪无遮挡十八禁网站| 久久精品国产亚洲av高清一级| 亚洲av欧美aⅴ国产| 国产黄色免费在线视频| 欧美人与性动交α欧美精品济南到| 成人黄色视频免费在线看| 国产成人一区二区三区免费视频网站| 午夜老司机福利片| 成人国语在线视频| 欧美中文综合在线视频| 最近最新中文字幕大全电影3 | 狂野欧美激情性xxxx| 国产激情久久老熟女| 丰满迷人的少妇在线观看| 久久国产亚洲av麻豆专区| 国产精品99久久99久久久不卡| 精品一区二区三区视频在线观看免费 | 欧美成人午夜精品| 法律面前人人平等表现在哪些方面| 午夜福利在线观看吧| 亚洲视频免费观看视频| 亚洲精品在线观看二区| 搡老岳熟女国产| 国产1区2区3区精品| 国产单亲对白刺激| 熟女少妇亚洲综合色aaa.| 久久久久精品国产欧美久久久| 国产在线精品亚洲第一网站| 99国产精品99久久久久| 国产精品亚洲av一区麻豆| 国产精品永久免费网站| 精品高清国产在线一区| av国产精品久久久久影院| 日日爽夜夜爽网站| 热99re8久久精品国产| 一级a爱片免费观看的视频| 国产1区2区3区精品| 很黄的视频免费| 大陆偷拍与自拍| 一级a爱片免费观看的视频| 欧美性长视频在线观看| 国产男女内射视频| 日韩大码丰满熟妇| 男女床上黄色一级片免费看| 热re99久久精品国产66热6| 国产乱人伦免费视频| 国产99久久九九免费精品| 色综合欧美亚洲国产小说| a在线观看视频网站| 免费高清在线观看日韩| av欧美777| 亚洲精品国产区一区二| 好看av亚洲va欧美ⅴa在| 久久久久精品国产欧美久久久| 国产熟女午夜一区二区三区| 大型av网站在线播放| 99国产精品免费福利视频| 男人舔女人的私密视频| 国产精品国产高清国产av | av免费在线观看网站| 精品少妇久久久久久888优播| 欧美丝袜亚洲另类 | 高潮久久久久久久久久久不卡| 如日韩欧美国产精品一区二区三区| 90打野战视频偷拍视频| 国产亚洲av高清不卡| 亚洲少妇的诱惑av| 天堂√8在线中文| 男女下面插进去视频免费观看| 欧美 亚洲 国产 日韩一| 校园春色视频在线观看| 在线观看免费日韩欧美大片| 午夜福利在线免费观看网站| 成年动漫av网址| 精品亚洲成a人片在线观看| 亚洲专区国产一区二区| 亚洲 欧美一区二区三区| 久久久久视频综合| 别揉我奶头~嗯~啊~动态视频| 免费女性裸体啪啪无遮挡网站| 亚洲视频免费观看视频| 99国产极品粉嫩在线观看| 黑人巨大精品欧美一区二区mp4| 国产99久久九九免费精品| 婷婷丁香在线五月| 91国产中文字幕| 亚洲av日韩精品久久久久久密| 成年动漫av网址| 12—13女人毛片做爰片一| 一本综合久久免费| 亚洲欧洲精品一区二区精品久久久| 日本一区二区免费在线视频| 一边摸一边抽搐一进一小说 | 欧洲精品卡2卡3卡4卡5卡区| 国产av又大| 久久天躁狠狠躁夜夜2o2o| 俄罗斯特黄特色一大片| 日本精品一区二区三区蜜桃| 免费少妇av软件| 亚洲专区中文字幕在线| 久久国产精品影院| 精品一区二区三区视频在线观看免费 | 国产成人欧美| 午夜91福利影院| 黄片播放在线免费| svipshipincom国产片| 日本wwww免费看| 午夜福利在线观看吧| videosex国产| 久久亚洲精品不卡| av天堂在线播放| 欧美 日韩 精品 国产| 欧美日韩精品网址| 亚洲色图综合在线观看| 久久久国产一区二区| 欧美日韩视频精品一区| 亚洲aⅴ乱码一区二区在线播放 | 成熟少妇高潮喷水视频| 国产欧美日韩综合在线一区二区| 亚洲av欧美aⅴ国产| 91av网站免费观看| 国产成人精品在线电影| 人人妻人人爽人人添夜夜欢视频| 一级a爱片免费观看的视频| 久久久久久人人人人人| 下体分泌物呈黄色| av电影中文网址| 99精品在免费线老司机午夜| 制服人妻中文乱码| 欧美成人免费av一区二区三区 | 在线av久久热| 中文字幕人妻熟女乱码| 成人黄色视频免费在线看| 国产精品 国内视频| 久久人妻福利社区极品人妻图片| 天堂√8在线中文| 久久亚洲精品不卡| 欧美精品高潮呻吟av久久| 久久精品国产a三级三级三级| 又紧又爽又黄一区二区| 亚洲欧美日韩高清在线视频| 国产高清videossex| 久久久国产一区二区| √禁漫天堂资源中文www| 男女高潮啪啪啪动态图| 丰满人妻熟妇乱又伦精品不卡| 日韩欧美在线二视频 | 伊人久久大香线蕉亚洲五| 一级黄色大片毛片| 欧美久久黑人一区二区| 老司机福利观看| 国产97色在线日韩免费| 99热网站在线观看| 中文字幕色久视频| 色综合欧美亚洲国产小说| 亚洲精品国产一区二区精华液| 婷婷丁香在线五月| 亚洲一区高清亚洲精品| 成熟少妇高潮喷水视频| 黄色丝袜av网址大全| 丰满人妻熟妇乱又伦精品不卡| 欧美大码av| 免费观看精品视频网站| 黄色毛片三级朝国网站| 午夜91福利影院| 国产成+人综合+亚洲专区| 欧美乱码精品一区二区三区| 香蕉久久夜色| 欧美人与性动交α欧美软件| 欧美国产精品va在线观看不卡| 成年人午夜在线观看视频| 欧美精品亚洲一区二区| 国产精品免费视频内射| 一二三四在线观看免费中文在| 成年版毛片免费区| 国产成+人综合+亚洲专区| 色综合婷婷激情| 王馨瑶露胸无遮挡在线观看| 美女福利国产在线| 亚洲av片天天在线观看| 王馨瑶露胸无遮挡在线观看| 天天躁日日躁夜夜躁夜夜| 日韩免费高清中文字幕av| 热99国产精品久久久久久7| 91在线观看av| av电影中文网址| 欧美人与性动交α欧美软件| 老司机亚洲免费影院| 无限看片的www在线观看| 欧美 亚洲 国产 日韩一| 亚洲午夜精品一区,二区,三区| 欧美日韩亚洲高清精品| av在线播放免费不卡| 99久久人妻综合| 国产亚洲精品第一综合不卡| 日韩 欧美 亚洲 中文字幕| 亚洲精品久久成人aⅴ小说| 国产精品久久久人人做人人爽| 国产精品香港三级国产av潘金莲| 1024视频免费在线观看| 欧美日本中文国产一区发布| 99在线人妻在线中文字幕 | 女人精品久久久久毛片| 国产麻豆69| 久久这里只有精品19| 久久精品亚洲av国产电影网| 国产精品偷伦视频观看了| 久久99一区二区三区| 最近最新免费中文字幕在线| a在线观看视频网站| 制服诱惑二区| 亚洲一卡2卡3卡4卡5卡精品中文| 午夜老司机福利片| 很黄的视频免费| 欧美一级毛片孕妇| 91麻豆av在线| 熟女少妇亚洲综合色aaa.| 精品欧美一区二区三区在线| 国产成人免费观看mmmm| 午夜老司机福利片| 久9热在线精品视频| tocl精华| 国产成人av教育| 亚洲免费av在线视频| 极品人妻少妇av视频| av片东京热男人的天堂| 老司机福利观看| 淫妇啪啪啪对白视频| 国产1区2区3区精品| 看片在线看免费视频| 国精品久久久久久国模美| 午夜91福利影院| 老司机亚洲免费影院| 一级a爱视频在线免费观看| 老司机在亚洲福利影院| 黄色成人免费大全| 侵犯人妻中文字幕一二三四区| 一二三四在线观看免费中文在| 国产成人欧美| 动漫黄色视频在线观看| 不卡一级毛片| www.自偷自拍.com| 欧美av亚洲av综合av国产av| 80岁老熟妇乱子伦牲交| 国产高清激情床上av| 亚洲av成人av| 国产伦人伦偷精品视频| 亚洲精品中文字幕一二三四区| 99riav亚洲国产免费| 免费在线观看黄色视频的| 99热网站在线观看| 国产激情久久老熟女| 亚洲在线自拍视频| 久久 成人 亚洲| 热99国产精品久久久久久7| 午夜两性在线视频| 极品少妇高潮喷水抽搐| 欧美激情 高清一区二区三区| 18禁国产床啪视频网站| 欧美激情极品国产一区二区三区| 国产精品.久久久| 最近最新中文字幕大全免费视频| av网站免费在线观看视频| 交换朋友夫妻互换小说| 18禁黄网站禁片午夜丰满| 中文字幕高清在线视频| 天天躁夜夜躁狠狠躁躁| 国产男女超爽视频在线观看| 69精品国产乱码久久久| 亚洲欧美激情综合另类| 一级片'在线观看视频| 黄片播放在线免费| 色播在线永久视频| 一级a爱视频在线免费观看| 超碰97精品在线观看| av线在线观看网站| 亚洲欧美色中文字幕在线| 18禁国产床啪视频网站| 少妇裸体淫交视频免费看高清 | 狠狠狠狠99中文字幕| 亚洲av熟女| a在线观看视频网站| 18禁裸乳无遮挡动漫免费视频| 国产精品免费大片| 黄色a级毛片大全视频| 成人精品一区二区免费| 亚洲五月色婷婷综合| 国产男靠女视频免费网站| 国产不卡av网站在线观看| 大香蕉久久网| 大型av网站在线播放| 成在线人永久免费视频| 色在线成人网| 欧美黄色片欧美黄色片| 人成视频在线观看免费观看| 色精品久久人妻99蜜桃| 亚洲国产精品一区二区三区在线| 国产又爽黄色视频| 夜夜躁狠狠躁天天躁| 久久精品国产综合久久久| 十八禁高潮呻吟视频| 国产一区有黄有色的免费视频| 亚洲第一青青草原| 满18在线观看网站| 无人区码免费观看不卡| www.精华液| 成人永久免费在线观看视频| 飞空精品影院首页| 国产主播在线观看一区二区| 国产精品自产拍在线观看55亚洲 | 成人永久免费在线观看视频| 欧美日韩黄片免| 午夜福利乱码中文字幕| 中文字幕另类日韩欧美亚洲嫩草| 亚洲色图 男人天堂 中文字幕| 午夜久久久在线观看| 高清欧美精品videossex| 久久人人97超碰香蕉20202| 一本一本久久a久久精品综合妖精| 男女下面插进去视频免费观看| av福利片在线| 91大片在线观看| 老司机在亚洲福利影院| 久久国产乱子伦精品免费另类| 亚洲中文av在线| 母亲3免费完整高清在线观看| 自拍欧美九色日韩亚洲蝌蚪91| 搡老熟女国产l中国老女人| 国产精品综合久久久久久久免费 | 黑丝袜美女国产一区| 午夜老司机福利片| av国产精品久久久久影院| 建设人人有责人人尽责人人享有的| 亚洲片人在线观看| 亚洲av日韩在线播放| 中文字幕色久视频| 午夜日韩欧美国产| 国产欧美日韩一区二区三区在线| 宅男免费午夜| 久久久久国内视频| 免费av中文字幕在线| 精品国产国语对白av| 亚洲全国av大片| 国产欧美亚洲国产| 亚洲色图 男人天堂 中文字幕| 搡老乐熟女国产| 老司机在亚洲福利影院| 精品一品国产午夜福利视频| 亚洲aⅴ乱码一区二区在线播放 | 99国产极品粉嫩在线观看| 国产亚洲欧美在线一区二区| 国产av又大| 亚洲精品av麻豆狂野| 成人av一区二区三区在线看| 免费在线观看完整版高清| 亚洲一区二区三区欧美精品| 国产精品永久免费网站| 97人妻天天添夜夜摸| 欧美黑人精品巨大| 最近最新免费中文字幕在线| 国产男女内射视频| 欧美日韩瑟瑟在线播放| 久久国产精品男人的天堂亚洲| 国产成人精品久久二区二区91| 久久久国产一区二区| 又黄又爽又免费观看的视频| 久久久国产欧美日韩av| 国产一区二区三区在线臀色熟女 | 这个男人来自地球电影免费观看| 久久久国产一区二区| av免费在线观看网站| 一进一出好大好爽视频| 国产精品久久视频播放| 正在播放国产对白刺激| 日韩中文字幕欧美一区二区| 久久中文看片网| 亚洲色图 男人天堂 中文字幕| 怎么达到女性高潮| 18禁观看日本| 久久精品人人爽人人爽视色| 免费在线观看亚洲国产| 国产成人精品久久二区二区免费| 亚洲精品在线观看二区| 日韩欧美免费精品| 免费久久久久久久精品成人欧美视频| 久久国产精品影院| 一本一本久久a久久精品综合妖精| 久久午夜亚洲精品久久| 看免费av毛片| 黑人巨大精品欧美一区二区蜜桃| 欧美日韩中文字幕国产精品一区二区三区 | 国产精品九九99| av福利片在线| 午夜91福利影院| 波多野结衣av一区二区av| 国产成人精品无人区| 看免费av毛片| 99国产极品粉嫩在线观看| 精品国产一区二区三区久久久樱花| 女人被狂操c到高潮| av电影中文网址| 日本欧美视频一区| 免费人成视频x8x8入口观看| 人妻久久中文字幕网| 97人妻天天添夜夜摸| 国产一卡二卡三卡精品| 国产精华一区二区三区| 两个人看的免费小视频| 丰满饥渴人妻一区二区三| 亚洲av电影在线进入| 99久久综合精品五月天人人| 一边摸一边抽搐一进一出视频| 欧美av亚洲av综合av国产av| 满18在线观看网站| 欧美国产精品一级二级三级| 变态另类成人亚洲欧美熟女 | 国产精品亚洲av一区麻豆| 亚洲午夜精品一区,二区,三区| 精品福利观看| 亚洲精品久久成人aⅴ小说| 一边摸一边抽搐一进一小说 | 精品国产一区二区三区四区第35| 男女免费视频国产| 欧美丝袜亚洲另类 | 欧美黄色片欧美黄色片| 如日韩欧美国产精品一区二区三区| 美女福利国产在线| 欧美精品高潮呻吟av久久| 国产精品久久视频播放| 怎么达到女性高潮| 免费看a级黄色片| 色精品久久人妻99蜜桃| 欧美乱码精品一区二区三区| 亚洲精品成人av观看孕妇| 80岁老熟妇乱子伦牲交| 操出白浆在线播放| www日本在线高清视频| 亚洲第一青青草原| av片东京热男人的天堂| 精品少妇一区二区三区视频日本电影| 19禁男女啪啪无遮挡网站| 欧美一级毛片孕妇| 国产99白浆流出| 少妇裸体淫交视频免费看高清 | 国产精品99久久99久久久不卡| 国产有黄有色有爽视频| 日日摸夜夜添夜夜添小说| 国产蜜桃级精品一区二区三区 | 亚洲精品中文字幕在线视频| 丝袜美腿诱惑在线| 91大片在线观看| 女人高潮潮喷娇喘18禁视频| 国产精品 国内视频| 亚洲精品久久午夜乱码| 精品一品国产午夜福利视频| tocl精华| 又黄又粗又硬又大视频| 亚洲视频免费观看视频| 亚洲人成电影免费在线| 欧美性长视频在线观看| 亚洲视频免费观看视频| 国产精品秋霞免费鲁丝片| 下体分泌物呈黄色| 欧美激情极品国产一区二区三区| 久久久国产一区二区| 999久久久国产精品视频| 交换朋友夫妻互换小说| 国精品久久久久久国模美| 亚洲精品久久成人aⅴ小说| 在线观看日韩欧美| 欧美国产精品va在线观看不卡| 1024香蕉在线观看| 18禁黄网站禁片午夜丰满| www日本在线高清视频| 啦啦啦 在线观看视频| 欧美日韩亚洲国产一区二区在线观看 | 国产1区2区3区精品| 免费少妇av软件| 亚洲一区二区三区欧美精品| 91精品国产国语对白视频| 久久精品国产亚洲av香蕉五月 | 国产99白浆流出| 欧美日韩乱码在线| 精品少妇久久久久久888优播| tube8黄色片| 久久九九热精品免费| 久久精品亚洲熟妇少妇任你| 久久久久精品人妻al黑| 校园春色视频在线观看| 老司机靠b影院| 一夜夜www| 一级毛片精品| 国产主播在线观看一区二区| 久久这里只有精品19| 国产99白浆流出| 免费女性裸体啪啪无遮挡网站| 最近最新中文字幕大全电影3 | 免费av中文字幕在线| 不卡一级毛片| 天堂中文最新版在线下载| 久久久久久久久免费视频了| 亚洲精品在线观看二区| 一级片免费观看大全| 中文字幕高清在线视频| av视频免费观看在线观看| 精品无人区乱码1区二区| 亚洲欧美精品综合一区二区三区| 免费高清在线观看日韩| 制服人妻中文乱码| 久久国产精品男人的天堂亚洲| 久99久视频精品免费| 99久久99久久久精品蜜桃| 宅男免费午夜| 自拍欧美九色日韩亚洲蝌蚪91| 欧美 日韩 精品 国产| 男女免费视频国产| 午夜日韩欧美国产| 亚洲成人国产一区在线观看| 777米奇影视久久| 婷婷精品国产亚洲av在线 | 无限看片的www在线观看| 岛国毛片在线播放| 国产aⅴ精品一区二区三区波| 在线永久观看黄色视频| 夫妻午夜视频| 一区福利在线观看| 久久久国产成人免费| 精品福利观看| 老司机影院毛片| 久久人人爽av亚洲精品天堂| 国产成人系列免费观看| 久9热在线精品视频| 99国产精品一区二区三区| 亚洲男人天堂网一区| 婷婷丁香在线五月| 国产日韩欧美亚洲二区| 精品国内亚洲2022精品成人 | 视频区欧美日本亚洲| 夜夜躁狠狠躁天天躁| 他把我摸到了高潮在线观看| 亚洲综合色网址| 成人av一区二区三区在线看| 超色免费av| 精品福利观看| 少妇裸体淫交视频免费看高清 | 飞空精品影院首页| 在线观看午夜福利视频| 久久精品亚洲熟妇少妇任你| 国产精品一区二区在线观看99| 怎么达到女性高潮| 亚洲男人天堂网一区| 日韩欧美在线二视频 | 女警被强在线播放| 每晚都被弄得嗷嗷叫到高潮| 大香蕉久久成人网| 欧美精品啪啪一区二区三区| 中文字幕人妻丝袜制服| 欧美日韩国产mv在线观看视频| 国产男女超爽视频在线观看| 91精品国产国语对白视频| 国产欧美亚洲国产| 脱女人内裤的视频| 男女床上黄色一级片免费看| av天堂久久9| 少妇被粗大的猛进出69影院| 一级片'在线观看视频| 国产又爽黄色视频| 婷婷丁香在线五月| 欧美精品高潮呻吟av久久| 亚洲精品乱久久久久久| 国产一区有黄有色的免费视频| 日本撒尿小便嘘嘘汇集6| 999久久久国产精品视频| 一区在线观看完整版| 免费在线观看影片大全网站| 欧美精品一区二区免费开放| 动漫黄色视频在线观看| 久久精品亚洲av国产电影网| 精品国产亚洲在线| 午夜精品在线福利| 12—13女人毛片做爰片一| 69精品国产乱码久久久| 久久久久久人人人人人| 中文字幕人妻熟女乱码| 纯流量卡能插随身wifi吗| 在线观看免费午夜福利视频| 亚洲 国产 在线| 日韩有码中文字幕| 久久婷婷成人综合色麻豆| 亚洲国产欧美一区二区综合| 又紧又爽又黄一区二区| 欧美成狂野欧美在线观看| 久久久久久久国产电影| 狂野欧美激情性xxxx| 久久国产乱子伦精品免费另类| 一进一出抽搐动态| 午夜两性在线视频| 日本a在线网址| 丝袜美足系列| 国产欧美亚洲国产| 免费av中文字幕在线|